top of page
Search

From activity to impact: rethinking how we measure medical affairs

Nov 4
3 min read

Updated: Nov 5

In October I gave a keynote at ISPSAI 2026, the International Summit on Pharmaceutical Sciences and AI Applications, in Paris, speaking on behalf of Bioveritas Partners. My thanks to Divya V and the team at Aver Conferences for the invitation.

Dr Barry Daly giving his keynote at ISPSAI 2026 in Paris.
Dr Barry Daly giving his keynote at ISPSAI 2026 in Paris.

My talk focused on two questions I hear from medical affairs teams again and again. How do we show the value of what we do? And how do we bring AI into our work without it becoming a collection of disconnected tools?


The activity trap

Medical affairs is still too often measured by activity: the number of MSL interactions logged, advisory boards held, congress meetings booked or slide decks delivered. These numbers are easy to count and easy to report. But they say very little about whether anything changed as a result.


Did a clinician's understanding of the data improve? Was an evidence gap identified and addressed? Did the insight we gathered shape the next study, the next piece of content or the launch plan? Those are the questions that matter, and an activity count cannot answer them.


When the scorecard rewards volume, teams naturally optimise for volume. That is not a criticism of the people doing the work. It is a predictable result of how we choose to measure them.


Adopting an impact mindset

An impact mindset starts at the other end. Instead of asking "how many?", it asks "what changed?". In practice that means:


  • Starting from clear medical objectives, not from activity targets.

  • Defining up front what change we expect to see, whether in understanding, in practice or in the evidence base.

  • Capturing scientific insight properly and feeding it back into strategy, rather than leaving it in a CRM field.

  • Judging engagement by its quality and relevance, not its frequency.


None of this is easy, and it takes time to build. But it gives medical teams a far more honest and useful way to show their contribution.


The wider team has to move too

Medical affairs cannot make this shift on its own. In many organisations the measures used for medical colleagues are set, or heavily influenced, by the wider cross-functional team: commercial, market access and senior leadership. If those colleagues continue to judge medical by activity metrics, that is what they will get.


The real progress comes when the whole team agrees what value from medical looks like, and measures it in a way that respects the scientific, non-promotional role medical plays.


Aligning AI with a scientific engagement model

The second part of my talk looked at AI. There is no shortage of tools on offer, and the temptation is to adopt them one at a time: a summarisation tool here, an insight dashboard there, a content assistant somewhere else. Introduced ad hoc, they rarely add up to much, and they can make an already fragmented picture worse.


A better approach is to start with a robust scientific engagement model: who we need to engage, why, with what evidence, and how insight flows back into the organisation. Once that model is clear, it becomes much easier to see where AI can genuinely strengthen it, and where it would simply add noise. The model should lead and the tools should follow, always within the ABPI Code and your own governance.


Looking ahead

These are exactly the conversations we have with clients at Bioveritas Partners, whether we are supporting field medical teams, KOL engagement or launch planning. If your team is wrestling with how to measure medical impact, or how to bring AI into scientific engagement in a structured way, I would be glad to talk.


We are already looking forward to next year's event in London.


 
 
imgi_3_molecular-Cg5p9BTS.jpg
LET'S TALK

Ready When You Are.

A 30-minute Discovery Call costs you nothing and tells us both whether we can help. Senior expertise across all six pillars, from the first conversation.

bottom of page